Sign up to access all valuation multiples
Zotefoams PLC is engaged in the manufacturing of polymer foam using bespoke autoclave technology to produce foams with attributes. Its block foams are sold under the AZOTE, T-FIT, ZOTEK, and other brand names. The company serves automotive, aerospace, packaging, industrial parts, marine, building and construction, military, medical, and sports and leisure industries. It has three main operating segments Polyolefin foams, High-Performance Products, and MuCell Extrusion LLC. The maximum revenue to the company is generated from the High-Performance Products.
1992
569
LTM Revenue $204M
LTM EBITDA $40.3M
$310M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Zotefoams has a last 12-month revenue (LTM) of $204M and a last 12-month EBITDA of $40.3M.
In the most recent fiscal year, Zotefoams achieved revenue of $198M and an EBITDA of $16.5M.
Zotefoams expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Zotefoams valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $204M | XXX | $198M | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | $61.9M | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | 31% | XXX | XXX | XXX |
| EBITDA | $40.3M | XXX | $16.5M | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 8% | XXX | XXX | XXX |
| EBIT | $27.6M | XXX | $24.3M | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 12% | XXX | XXX | XXX |
| Net Profit | $12.8M | XXX | -$3.7M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | -2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $32.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of September 5, 2025, Zotefoams's stock price is GBP 4 (or $6).
Zotefoams has current market cap of GBP 202M (or $271M), and EV of GBP 231M (or $310M).
See Zotefoams trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $310M | $271M | XXX | XXX | XXX | XXX | $0.39 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of September 5, 2025, Zotefoams has market cap of $271M and EV of $310M.
Zotefoams's trades at 1.6x EV/Revenue multiple, and 18.8x EV/EBITDA.
Equity research analysts estimate Zotefoams's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Zotefoams has a P/E ratio of 21.2x.
See valuation multiples for Zotefoams and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $271M | XXX | $271M | XXX | XXX | XXX |
| EV (current) | $310M | XXX | $310M | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | 7.7x | XXX | 18.8x | XXX | XXX | XXX |
| EV/EBIT | 11.2x | XXX | 12.7x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | 21.2x | XXX | -73.2x | XXX | XXX | XXX |
| EV/FCF | 29.0x | XXX | 20.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialZotefoams's last 12 month revenue growth is 5%
Zotefoams's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Zotefoams's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Zotefoams's rule of X is 31% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Zotefoams and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 20% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | 15% | XXX | XXX | XXX |
| Rule of 40 | 23% | XXX | 13% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 31% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 6% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Accsys Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Merck KGaA | XXX | XXX | XXX | XXX | XXX | XXX |
| Posco Future | XXX | XXX | XXX | XXX | XXX | XXX |
| Cosmo Advanced Materials | XXX | XXX | XXX | XXX | XXX | XXX |
| Daejoo Electronic | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Zotefoams acquired XXX companies to date.
Last acquisition by Zotefoams was XXXXXXXX, XXXXX XXXXX XXXXXX . Zotefoams acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Zotefoams founded? | Zotefoams was founded in 1992. |
| Where is Zotefoams headquartered? | Zotefoams is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Zotefoams have? | As of today, Zotefoams has 569 employees. |
| Who is the CEO of Zotefoams? | Zotefoams's CEO is Mr. Ronan Michael Cox. |
| Is Zotefoams publicy listed? | Yes, Zotefoams is a public company listed on LON. |
| What is the stock symbol of Zotefoams? | Zotefoams trades under ZTF ticker. |
| When did Zotefoams go public? | Zotefoams went public in 1995. |
| Who are competitors of Zotefoams? | Similar companies to Zotefoams include e.g. Accsys Technologies, Merck KGaA, Posco Future, Cosmo Advanced Materials. |
| What is the current market cap of Zotefoams? | Zotefoams's current market cap is $271M |
| What is the current revenue of Zotefoams? | Zotefoams's last 12 months revenue is $204M. |
| What is the current revenue growth of Zotefoams? | Zotefoams revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Zotefoams? | Current revenue multiple of Zotefoams is 1.5x. |
| Is Zotefoams profitable? | Yes, Zotefoams is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Zotefoams? | Zotefoams's last 12 months EBITDA is $40.3M. |
| What is Zotefoams's EBITDA margin? | Zotefoams's last 12 months EBITDA margin is 20%. |
| What is the current EV/EBITDA multiple of Zotefoams? | Current EBITDA multiple of Zotefoams is 7.7x. |
| What is the current FCF of Zotefoams? | Zotefoams's last 12 months FCF is $10.7M. |
| What is Zotefoams's FCF margin? | Zotefoams's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Zotefoams? | Current FCF multiple of Zotefoams is 29.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
